Name | Title | Contact Details |
---|
Bionix Medical Technologies has provided medical professionals with innovative medical devices since 1984. Bionix is proud to offer cerumen removal, wound care, feeding tube care, infant feeding, bolus control and nasal visualization products.
Twin Medical Co is a Ephrata, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Athena Feminine Technologies is a Orinda, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company`s focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S. Approximately 1.7 million Americans have AAA, and the incidence of the condition increases with age. Endologix is currently marketing the AFX® Endovascular AAA System is available in the U.S., Europe, Latin America and other regions. The Nellix® EndoVascular Aneurysm Sealing System, a novel aneurysm sealing system, is approved for sale in Europe and other markets and for investigational use in the U.S. The Powerlink with IntuiTrak® Delivery System is available in Japan. These technologies are minimally invasive, allowing for greater patient comfort and quicker recovery compared to invasive surgical alternatives. Endologix products are protected by at least 52 U.S. patents with at least 956 allowed claims. Endologix is a publicly-held company trading on NASDAQ: ELGX. The Company`s corporate office is located in Irvine, California.
New York Blood Center (NYBC) is one of the nation`s largest non-profit, community-based blood centers. NYBC has been providing blood, transfusion products and services to over 150 hospitals, serving 20 million people, in greater New York since 1964. NYBC is also home to the Lindsley F. Kimball Research Institute and the National Cord Blood Program at the Howard P. Milstein National Cord Blood Center, the world`s largest public cord blood bank. NYBC provides medical services and programs (Clinical, Transfusion, and Hemophilia Services) through our medical professionals along with consultative services in transfusion medicine.